Condom use among young women in Australia using long-acting reversible contraceptives or other hormonal contraceptives

被引:9
|
作者
Nguyen, Julie [1 ]
Williams, Henrietta [1 ,2 ]
McNamee, Kathleen [3 ,4 ]
Shaffeu, Nabreesa [1 ]
Vaisey, Alaina [1 ]
Hocking, Jane [1 ]
机构
[1] Univ Melbourne, Sch Populat & Global Hlth, 207 Bouverie St, Carlton, Vic 3053, Australia
[2] Melbourne Sexual Hlth Ctr, 580 Swanston St, Carlton, Vic 3053, Australia
[3] Family Planning Victoria, 901 Whitehorse Rd, Box Hill, Vic 3128, Australia
[4] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia
基金
英国医学研究理事会;
关键词
dual contraceptive methods; sexually transmissible infections; DUAL METHOD USE; ADOLESCENTS; PROTECTION; IMPLANT; HEALTH; LARC;
D O I
10.1071/SH19045
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Dual condom and long-acting reversible contraceptive (LARC) or non-LARC hormonal contraceptive use is the most effective way to protect against unwanted pregnancy and sexually transmissible infections (STIs). This study aimed to determine whether condom use varied between users of LARC and non-LARC hormonal contraceptives and explore their motivations for condom use. Methods: Women aged 16-24 years attending a sexual and reproductive health centre in Melbourne, Australia, completed a survey about contraceptives and sexual practices. The proportion of LARC and non-LARC hormonal contraceptive users using condoms was calculated and logistic regression compared condom use between the two groups. Condom use was based on frequency of use and coded as a binary variable 'never, not usually or sometimes' versus 'usually or always'. Results: In all, 294 (97%) women participated in the study; 23.8% (95% confidence interval (CI) 19.0-29.1%) used LARC and 41.7% (95% CI 36.0-47.6%) used non-LARC hormonal contraceptives. Condom use was reported by 26.1% (95% CI 16.3-38.1%) of LARC users and by 27.8% (95% CI 19.9-37.0%) of non-LARC hormonal contraceptive users. There was no difference in condom use between groups (odds ratio (OR) 0.9; 95% CI 0.4-1.9). Condom use reduced with increasing relationship length (>= 6 months vs no relationship: OR 0.2; 95% CI 0.1-0.6). Non-LARC hormonal contraceptive users were more motivated to use condoms if worried about pregnancy than LARC users (62.8% vs 47.8%; P = 0.04). Conclusion: Condom use was low and similar between users of LARC and non-LARC hormonal contraceptives, and was associated with the length of the relationship. These results highlight the need to promote condom use when prescribing LARCs and non-LARC hormonal contraceptives to reduce the risk of STIs.
引用
收藏
页码:574 / 579
页数:6
相关论文
共 50 条
  • [41] Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents
    Kortsmit, Katherine
    Williams, Letitia
    Pazol, Karen
    Smith, Ruben A.
    Whiteman, Maura
    Barfield, Wanda
    Koumans, Emilia
    Kourtis, Athena
    Harrison, Leslie
    Bauman, Brenda
    Warner, Lee
    JAMA PEDIATRICS, 2019, 173 (07) : 663 - 670
  • [42] Long-Acting Reversible Contraceptives for Incarcerated Women: Feasibility and Safety of On-Site Provision
    Sufrin, Carolyn
    Oxnard, Tianyi
    Goldenson, Joe
    Simonson, Kristin
    Jackson, Andrea
    PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2015, 47 (04) : 203 - 211
  • [43] Long Acting Reversible Contraceptives: Knowledge and Attitude among Married Women of Lahore
    Jabeen, Chanda
    Umbreen, Gulshan
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2016, 15 (03): : 121 - 127
  • [44] Uptake of long-acting reversible contraceptives among post abortion clients in Sargodha, Pakistan
    Maqbool, Saadia
    Shan, Hina
    Manzoor, Iram
    RAWAL MEDICAL JOURNAL, 2021, 46 (03): : 716 - 720
  • [45] REQUIREMENTS OR INCENTIVES BY GOVERNMENT FOR THE USE OF LONG-ACTING CONTRACEPTIVES
    ORENTLICHER, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (13): : 1818 - 1821
  • [46] The Tupange Project in Kenya: A Multifaceted Approach to Increasing Use of Long-Acting Reversible Contraceptives
    Muthamia, Michael
    Owino, Kenneth
    Nyachae, Paul
    Kilonzo, Margaret
    Kamau, Mercy
    Otai, Jane
    Kabue, Mark
    Keyonzo, Nelson
    GLOBAL HEALTH-SCIENCE AND PRACTICE, 2016, 4 : S44 - S59
  • [47] Benefits from Long-acting reversible contraceptives (LARC) use in adolescents and the role of paediatricians
    Zampetaki, Charisti
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 176 - 177
  • [48] EVALUATING THE USE OF LONG-ACTING REVERSIBLE CONTRACEPTIVES; WHAT CAN BE DONE TO IMPROVE UPTAKE?
    Gorman, Caitlin
    Tensel, Wesley
    SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 : A33 - A33
  • [49] EVALUATING THE USE OF LONG-ACTING REVERSIBLE CONTRACEPTIVES; WHAT CAN BE DONE TO IMPROVE UPTAKE?
    Gorman, Caitlin
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05): : E334 - E334
  • [50] The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations
    Bahamondes, Luis
    Villarroel, Claudio
    Frias Guzman, Natalia
    Oizerovich, Silvia
    Velazquez-Ramirez, Norma
    Monteiro, Ilza
    HUMAN REPRODUCTION OPEN, 2018, 2018 (01)